Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EM

Ehud Marom — 34 Patents

MPMapi Pharma: 33 patents #1 of 11Top 10%
SMStem Cell Medicine: 3 patents #1 of 6Top 20%
Tel Aviv-Yafo, IL: #62 of 1,860 inventorsTop 4%
Overall (All Time): #100,737 of 4,157,543Top 3%
34 Patents All Time
Ehud Marom has been granted 34 US patents while listed as an inventor at Mapi Pharma. The first was granted in 2013 and the most recent in July 2025. Ehud Marom ranks #100,737 of 4,157,543 US inventors in our database (top 2.4%). Patent records list Ehud Marom in Tel Aviv-Yafo, IL.

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #TitleCo-InventorsDate
12370233 Depot systems comprising glatiramer acetate Nadav BLEICH KIMELMAN, Uri Danon, Shai Rubnov 2025-07-29
12343371 Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate Uri Danon, Nadav BLEICH KIMELMAN, Laura Popper 2025-07-01
12251380 Depot systems comprising cariprazine or salts thereof Shai Rubnov, Anna Gopin 2025-03-18
RE50301 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof Shai Rubnov 2025-02-18
12161688 Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells Nadav BLEICH KIMELMAN, Frida Grynspan 2024-12-10
12097292 Process for preparing microparticles containing glatiramer acetate Nadav BLEICH KIMELMAN, Shai Rubnov 2024-09-24
11931357 Depot systems comprising Cariprazine or salts thereof Shai Rubnov, Anna Gopin 2024-03-19
11865213 Semaglutide depot systems and use thereof Galina ZATS, Nadav BLEICH KIMELMAN, Shai Rubnov 2024-01-09
11510946 Treatment of multiple sclerosis with adipose-derived stem cells Frida Grynspan, Dima Yudin 2022-11-29
11471421 Process for preparing microparticles containing glatiramer acetate Nadav BLEICH KIMELMAN, Shai Rubnov 2022-10-18
RE49251 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof Shai Rubnov 2022-10-18
11413311 Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells Nadav BLEICH KIMELMAN, Frida Grynspan 2022-08-16
11167003 Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems Uri Danon, Nadav BLEICH KIMELMAN, Laura Popper 2021-11-09
10493122 Sublingual delivery of glatiramer acetate Yoram Sela, Nadav BLEICH KIMELMAN 2019-12-03
10111867 Process and intermediates for the preparation of perampanel Shai Rubnov 2018-10-30
9994522 Amorphous form of apremilast Shai Rubnov 2018-06-12
9617241 Intermediate compounds and process for the preparation of efinaconazole Anna Gopin, Shai Rubnov, Galina ZATS 2017-04-11
9453024 Polymorphs of darunavir 2016-09-27
9206197 Amorphous form of dolutegravir Shai Rubnov 2015-12-08
9200114 Random pentapolymer for treatment of autoimmune diseases Shai Rubnov 2015-12-01
9102592 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium Michael Mizhiritskii, Shai Rubnov 2015-08-11
9096574 Polymorphs of perampanel Shai Rubnov 2015-08-04
9006188 Co-crystals of dapagliflozin Shai Rubnov 2015-04-14
8981095 Intermediate compounds and process for the preparation of lurasidone and salts thereof Michael Mizhiritskii, Susanna Tchilibon, Shai Rubnov 2015-03-17
8975244 Process and intermediates for the preparation of abiraterone acetate Shai Rubnov, Michael Mizhiritskii 2015-03-10